Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma

Clinical trial NCT01582776 · COMPLETED

Trial details

NCT number: NCT01582776
Sponsor: The Lymphoma Academic Research Organisation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma Patients (Phase IB)Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)

Start date: 2012-10-03
Primary completion: 2018-07-11
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.